Skip to main content
Log in

Anticancer activities of trichostatin A on malignant lymphoid cells

  • Published:
Journal of Huazhong University of Science and Technology Aims and scope Submit manuscript

Summary

The anticancer activity of trichostain A (TSA) on human B cell non-Hodgkin’s lymphoma and its mechanism were explored. The effect of TSA on the growth of Raji cells and normal peripheral blood mononuclear cells (NPBMNC) was studied by MTT assay. The effect of TSA on the apoptosis of Raji cells and NPBMNC was studied by flow cytometry and TDT-mediated dUTP nick end labeling (TUNEL). The effect of TSA on the cell cycle of Raji cells was studied by propidium iodide method. The results showed that TSA potently inhibited proliferation of Raji cells at microgram concentrations and induced apoptosis of Raji cells in a time-and concentration-dependent manner. Treatment with TSA induced accumulation of cells in G0/G1 or G2/M and a concomitant decrease of cell population in S phase. However, NPBMNC was less sensitive to the cytotoxic effect of TSA than Raji cells. It was concluded that TSA may inhibit the proliferation of Raji cells by regulating the cell cycle and inducing the cell apoptosis. Moreover, TSA demonstrates low toxicity in NPBMNC but selectively induces apoptosis of Raji cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cress W D, Steo E. Histone deacetylase, transcriptional control and cancer. J Cell Physiol, 2000,184:1–16

    Article  PubMed  CAS  Google Scholar 

  2. Chen W K, Chen Y. Histone acetylation: new target for leukemia treatment. Clin J Hematol (Chinese), 2002,15:233–234

    Google Scholar 

  3. Finnin M S, Donigian J R, Cohen A et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature, 1999,401:188–193

    Article  PubMed  CAS  Google Scholar 

  4. Wang Z M, Hu J, Zhou D et al. Trichostatin A inhibits proliferation and induces expression of P21WAF and P27 in human brain tumor cell lines. Chin J Cancer (Chinese), 2002,21:1100–1105

    Google Scholar 

  5. Herold C, Ganslmayer M, Ocker M et al. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol, 2002,36:233–240

    Article  PubMed  CAS  Google Scholar 

  6. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983,65:55–63

    Article  PubMed  CAS  Google Scholar 

  7. Park W H, Jung C W, Park J O et al. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. Int J Oncol, 2003,22:1129–1134

    PubMed  CAS  Google Scholar 

  8. Medina V, Edmonds B, Young G P et al. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitor of histone deacetylase): dependence on protein synthesis and synergy with a mitochodrial/cytochrome c-dependent pathway. Cancer Res, 1997,57:3697–3707

    PubMed  CAS  Google Scholar 

  9. Murata M, Towatari M, Kosugi H et al. Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells. Jpn J Cancer Res, 2000,91:1154–1160

    PubMed  CAS  Google Scholar 

  10. Owa T, Yoshino H, Yoshimatsu K et al. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem, 2001,8:1487–1503

    PubMed  CAS  Google Scholar 

  11. Huaang L, Pardee A B. Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. Mol Med, 2000,6:849–866

    Google Scholar 

  12. Sowa Y, Sakai T. Butyrate as a model for “gene-regulating chemoprevention and chemotherapy”. Biofactors, 2000,12:283–287

    PubMed  CAS  Google Scholar 

  13. Munster P N, Troso-Sandoval T, Rosen N et al. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. Cancer Res, 2001,61(23):8492–8497

    PubMed  CAS  Google Scholar 

  14. Hoshikawa Y, Kwon H J, Yoshida M et al. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. Exp Cell Res, 1994,214:189–197

    Article  PubMed  CAS  Google Scholar 

  15. Vigushin D M, Ali S, Pace P E et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res, 2001,7(4):971–976

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This project was supported by a grant from National Natural Sciences Foundation of China (No. 30271672).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, C., Liu, X., Chen, Y. et al. Anticancer activities of trichostatin A on malignant lymphoid cells. J. Huazhong Univ. Sc. Technol. 26, 538–541 (2006). https://doi.org/10.1007/s11596-006-0513-8

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-006-0513-8

Key words

Navigation